The KHDRBS2 antibody is a tool used to detect the KHDRBS2 protein, a member of the KH domain-containing RNA-binding signal transduction-associated (KHDRBS) family. Also known as SLM2 or HNRPA1B, KHDRBS2 is an RNA-binding protein involved in post-transcriptional gene regulation, including mRNA splicing, stability, and transport. It contains a conserved KH domain that mediates interactions with RNA and proteins, playing roles in cellular processes such as neuronal development, cell differentiation, and signal transduction.
KHDRBS2 is expressed in various tissues, with higher levels observed in the brain, suggesting its importance in neurodevelopment and synaptic plasticity. Dysregulation of KHDRBS2 has been linked to neurological disorders, such as autism spectrum disorders, and cancers, where it may influence tumor progression via alternative splicing or RNA metabolism.
The KHDRBS2 antibody is widely utilized in research applications like Western blotting, immunohistochemistry, and immunofluorescence to study its expression, localization, and function. It aids in exploring KHDRBS2's mechanistic roles in disease models and its potential as a therapeutic target. Validation of antibody specificity is critical, often confirmed using knockout controls or siRNA-mediated knockdown to ensure accurate detection in experimental systems.